For the first time in many years, the overall MS market actually declined in revenues in 2009, although the 2.5% contraction in demand was fairly small compared to the broader analytical instrument market, let alone the broader economy. IBO expects the MS market to rebound significantly in 2010, growing 8.2% and reaching nearly $2.5 billion […]
The market for separations techniques was hit hard in 2009 due to weakness in the industrial segments, including the chemicals industry, and the pharmaceutical industry. The separations market declined 5.7% in 2009 and accounted for $6.2 billion in sales. While the market is not expected to make a full recovery just yet, it is estimated […]
The Great Recession The overall downturn in demand for laboratory instruments and other laboratory products continued into 2009, as the world economy was largely stagnant before a gradual recovery mid-year. Sales to industrial end-markets were the weakest, as companies slowed or shut down production lines and delayed new projects. New instrument sales suffered as customers […]
It is that time of the year again to peer into our crystal ball and proffer the future of the analytical and life science instrument industry. This year’s task is somewhat easier than that which confronted IBO in January 2009 (see IBO 1/15/09), although some uncertainty still persists. A year ago we were trying to […]
The American Society for Cell Biology held its 49th annual meeting from December 5 to 9, 2009. Despite rather miserable weather, the show drew about 9,000 people to the San Diego Convention Center in California. It featured a solid technical program, which included over 100 oral presentations and more than 3,500 poster sessions. In addition, […]
This month, President Obama signed the US Department of Health and Human Services’ (HHS) appropriations bill for fiscal 2010, starting October 1, 2009 (see IBO 12/15/09). The HHS budget increased 5.3% to $803.5 billion The National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC), both part of the HHS, benefited […]
In 2009, the world economic downturn exposed a fragile and unregulated global financial system. Virtually every economy was impacted by the collapse of the financial system, as the Morgan Stanley Capital International (MSCI) All-Country World Index fell 24.1% during the first quarter of 2009. However, a concerted effort by international governments to support the credit […]
As IBO noted in its annual review of instrument and lab product company acquisitions (see IBO 11/15/09), the number of acquisitions picked up as 2009 progressed. This pace could continue, according to indications from several major companies. QIAGEN CFO Roland Sackers told Bloomberg in November that the company could spend as much as $200–$500 million […]
Third-quarter 2009 Life Science Index sales grew 1.0% to $2,357.62 million. Operating profit climbed 10.9% to $420.02 million, and operating margins gained 160 basis points to 17.8% of sales. Affymetrix’s third-quarter revenues fell 4.0%, 2.5% on a currency-neutral basis, to $78.2 million due to lower instrument sales. Product revenue improved 0.3% to $66.2 million, including […]
Thermal desorption is considered one of the most sensitive and environmental friendly sample introduction techniques for GC and GC/MS. Thermal desorption is used for the analysis of volatile organic compounds (VOCs) and semi-VOCs. Thermal desorption systems have been available for more than two decades and have shown few technical advancements in recent years, making them […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
